Melt Pharmaceuticals is focused on the development of a novel approach to providing procedural sedation and analgesia for short-term medical procedures. Our novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers.
Location: United States, Massachusetts, Needham
Employees: 1-10
Total raised: $24M
Founded date: 2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.04.2024 | Series B | $24M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 04.04.2024 | Melt Pharmaceuticals Revolutionizes Sedation with $24M Serie... | Nashville's Melt Pharmaceuticals secures $24 million in Series B funding to propel the development o... | parsers.vc... |
| 02.04.2024 | Melt Pharmaceuticals Closes $24M in Series B Funding Preferr... | Melt Pharmaceuticals, a Nashville, TN-based clinical‑stage pharmaceutical company, raised $24M in Se... | finsmes.co... |
| 02.04.2024 | Melt Pharmaceuticals Inks $24M Series B | NASHVILLE, TN, Melt Pharmaceuticals today announced the completion of its Series B Preferred Stock... | vcnewsdail... |
| 10.11.2021 | Q3-2021 Letter to Stockholders | Harrow Health, Inc. Letter to Stockholders November 9, 2021 To the Stockholders of Harrow Health, In... | marketscre... |
| 02.09.2021 | Harrow Health : Provides $13.5 Million Senior Secured Loan t... | Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, and Melt Pharmaceutica... | marketscre... |
| 02.09.2021 | Harrow Health : Provides $13.5 Million Senior Secured Loan t... | Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals Melt Expects to Dos... | marketscre... |
| 10.08.2021 | Harrow Health : Q2-2021 Letter to Stockholders | Harrow Health, Inc. Letter to Stockholders August 10, 2021 To the Stockholders of Harrow Health, Inc... | marketscre... |
| - | Melt Pharmaceuticals | “The Investor Relations website contains information about Melt Pharmaceuticals's business for stock... | fastfounde... |